UnknownNot Applicable

Describe Relations Between qCON and qNOX Indicies During Propofol-Remifentanil General Anesthesia

Italy14 participantsStarted 2024-04-01

Plain-language summary

CONOX is a neuromonitoring EEG- device for sedation (qCON) and analgesia (qNOX) monitoring during general anesthesia. It is unknown on how the indicies can differentiate themselves so aim of this study is to determine the relationship bewtween the 2 indicies.

Who can participate

Age range18 Years – 90 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Undergo general anaesthesia with Targeted Controlled Infusion of Propofol (Eleveld or Schnider model) and Remifentanil (Minto model) and CONOX monitoring Exclusion Criteria: * Neurological disease * Psychiatric disease * Obesity * Locoregional anesthesia

What they're measuring

Correlation between qCON and qNOX

Timeframe: CONOX values will be recorded from start of anesthesia to the return of responsiveness at the end of surgery

Trial details

NCT IDNCT06349681

SponsorUniversity of Padova

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2024-09-01

Contact for this trial

Federico Linassi, MD

0422322440 federico.linassi@gmail.com

View on ClinicalTrials.gov More Anesthesia Brain Monitoring trials